A Battle of Technologies: Immunoassay or Mass Spectrometry Testing for Therapeutic Drug Monitoring. // Clinics in Laboratory Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S0272271226000752?dgcid=rss_sd_all
A Battle of Technologies: Immunoassay or Mass Spectrometry Testing for Therapeutic Drug Monitoring. Clinics in Laboratory Medicine. https://www.sciencedirect.com/science/article/pii/S0272271226000752?dgcid=rss_sd_all
“A Battle of Technologies: Immunoassay or Mass Spectrometry Testing for Therapeutic Drug Monitoring.” Clinics in Laboratory Medicine.
@article{article41766,
title = {A Battle of Technologies: Immunoassay or Mass Spectrometry Testing for Therapeutic Drug Monitoring},
journal = {Clinics in Laboratory Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S0272271226000752?dgcid=rss_sd_all}
}
ABSTRACT Three‐dimensional (3D) printing enables precise control over scaffold geometry, porosity, material distribution, and spatial delivery of cells and bioactive cues. However, features intended to improve biological fidelity often...